Table 2

Distribution of valvular regurgitation at initial echocardiogram in 918 men exposed to fenfluramine and/or dexfenfluramine


Ages

<20 (n = 12)
20–29 (n = 31)
30–39 (n = 125)
40–49 (n = 249)
50–59 (n = 281)
60–69 (n = 166)
70+ (n = 54)
All ages (n = 918)

Aortic regurgitation








     None (%)
91.7
90.3
86.4
79.5
73.7
62.0
55.6
74.6
     Trace (%)
8.3
9.7
10.4
13.6
12.8
24.1
27.8
15.5
     Mild (%)
0
0
2.4
4.8
12.1
8.4
13.0
7.6
     moderate (%)
0
0
0.80
2.0
1.4
4.2
3.7
2.1
     severe (%)
0
0
0
0
0
1.2
0
0.22
Mitral regurgitation








     none (%)
58.3
58.1
48.0
44.2
35.9
34.9
44.4
41.2
     trace (%)
33.3
35.5
48.0
48.6
54.4
47.6
46.3
49.4
     Mild (%)
8.3
3.2
4.0
7.2
7.5
9.6
5.6
7.1
     moderate (%)
0
0
0
0
1.1
6.0
3.7
1.6
     severe (%)
0
3.2
0
0
1.1
1.8
0
0.76
Tricuspid regurgitation








     none (%)
41.7
38.7
37.6
34.1
31.7
26.5
31.5
32.5
     trace (%)
33.3
51.6
60.0
56.6
62.6
59.6
55.6
59.0
     Mild (%)
16.7
9.7
2.4
7.2
4.3
9.0
9.3
6.3
     moderate (%)
0
0
0
2.0
0.71
4.2
3.7
1.7
     severe (%)
8.3
0
0
0
0.71
0.60
0
0.44

Dahl et al. BMC Medicine 2008 6:34   doi:10.1186/1741-7015-6-34